Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 6/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | CYCS | P99999 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3527817 | 0.86 | TERT (0.39) | TERTABCG2TOP1CYCS | |
| Hydrochloric Acid SCHEMBL1410312 | 0.78 | TERT (0.50) | TERTTOP1CYCS | |
| SCHEMBL29869092 | 0.69 | TERT (0.49) | TERTTOP1CYCS | |
| SCHEMBL448020 | 0.69 | TERT (0.49) | TERTTOP1CYCS | |
| SCHEMBL1517327 | 0.69 | ABCG2 (0.53) | TERTABCG2TOP1CYCS | |
| SCHEMBL9998554 | 0.69 | TERT (0.36) | TERTABCG2TOP1CYCS | |
| SCHEMBL451589 | 0.68 | CA1 (0.41) | TERT | |
| SCHEMBL3521676 | 0.65 | TERT (0.42) | TERTABCG2TOP1CYCS | |
| SCHEMBL3308268 | 0.64 | ACHE (0.49) | — | |
| SCHEMBL1410057 | 0.64 | TERT (0.47) | TERTABCG2TOP1CYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183364-B2 | Substituted porphyrins | DUKE UNIVERSITY (US) | 2012-05-22 | — | — | US | disclosed |
| US-20100305083-A1 | SUBSTITUTED PORPHYRINS | BATINIC-HABERLE INES | 2010-12-02 | — | — | US | disclosed |
| US-7807825-B2 | Substituted porphyrins | DUKE UNIVERSITY (US) | 2010-10-05 | — | — | US | disclosed |
| US-20080021007-A1 | Substituted Porphyrins | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-01-24 | — | — | US | disclosed |
| EP-1718201-A1 | SUBSTITUTED PORPHYRINS | Duke University (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005077269-A1 | SUBSTITUTED PORPHYRINS | DUKE UNIVERSITY (US) | 2005-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021007-A1 | Substituted Porphyrins | SOD3, SOD1, PRDX3 | TERT 1529/4885ABCG2 1325/4885TOP1 3229/4885 |
| US-20100305083-A1 | SUBSTITUTED PORPHYRINS | SOD3, SOD1, PRDX3 | TERT 1424/4885ABCG2 1434/4885TOP1 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.